BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cedro-Tanda A, Gómez-Romero L, Alcaraz N, de Anda-Jauregui G, Peñaloza F, Moreno B, Escobar-Arrazola MA, Ramirez-Vega OA, Munguia-Garza P, Garcia-Cardenas F, Cisneros-Villanueva M, Moreno-Camacho JL, Rodriguez-Gallegos J, Luna-Ruiz Esparza MA, Fernández Rojas MA, Mendoza-Vargas A, Reyes-Grajeda JP, Campos-Romero A, Angulo O, Ruiz R, Sheinbaum-Pardo C, Sifuentes-Osornio J, Kershenobich D, Hidalgo-Miranda A, Herrera LA. The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City. Viruses 2021;13:2182. [PMID: 34834987 DOI: 10.3390/v13112182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Serna-muñoz R, Hernández-terán A, Soto-nava M, Tapia-trejo D, Ávila-ríos S, Mejía-nepomuceno F, García E, Castillejos-lópez M, Higuera-iglesias AL, Aquino-gálvez A, Thirion-romero I, Pérez-padilla R, Aguilar-faisal JL, Vázquez-pérez JA. Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes. Vaccines 2022;10:2063. [DOI: 10.3390/vaccines10122063] [Reference Citation Analysis]
2 Haan TJ, Smith LK, DeRonde S, House E, Zidek J, Puhak D, Redlinger M, Parker J, Barnes BM, Burkhead JL, Knall C, Bortz E, Chen J, Drown DM. Pattern of SARS-CoV-2 variant B.1.1.519 emergence in Alaska. Sci Rep 2022;12:20662. [PMID: 36450812 DOI: 10.1038/s41598-022-25373-1] [Reference Citation Analysis]
3 Sifuentes-osornio J, Angulo-guerrero O, De Anda-jáuregui G, Díaz-de-león-santiago JL, Hernández-lemus E, Benítez-pérez H, Herrera LA, López-arellano O, Revuelta-herrera A, Rosales-tapia AR, Suárez-lastra M, Kershenobich D, Ruiz-gutiérrez R. Probability of hospitalisation and death among COVID-19 patients with comorbidity during outbreaks occurring in Mexico City. J Glob Health 2022;12:05038. [DOI: 10.7189/jogh.12.05038] [Reference Citation Analysis]
4 Hernández-Terán A, Garcíadiego-Fossas P, Villanueva-Reza M, Boukadida C, Taboada B, Porras E, Ahumada-Topete V, Tapia-Diaz KE, Matías-Florentino M, Pérez-García M, Ávila-Ríos S, Mejía-Nepomuceno F, Serna-Muñoz R, Juárez-Hernández F, Jiménez-Corona ME, Becerril-Vargas E, Barreto O, Martínez-Orozco JA, Pérez-Padilla R, Arias CF, Vázquez-Pérez JA. Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City. Vaccines (Basel) 2022;10:1181. [PMID: 35893830 DOI: 10.3390/vaccines10081181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Castelán-sánchez HG, Delaye L, Inward RPD, Dellicour S, Gutierrez B, de la Vina NM, Pybus OG, de Anda Jáuregui G, Guzmán P, Garrido MF, Fontanelli Ó, Rosales MH, Meneses A, Olmedo-alvarez G, Herrera-estrella A, Boukadida C, Sanchez-flores A, Muñoz-medina JE, Comas-garcía A, Gómez-gil B, Zárate S, Taboada B, López S, Arias CF, Kraemer MU, Lazcano A, Escalera-zamudio M. “Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico”.. [DOI: 10.1101/2022.07.05.498834] [Reference Citation Analysis]
6 Garcia-cardenas F, Peñaloza F, Bertin-montoya J, Valdéz-vázquez R, Franco A, Cortés R, Frias-jimenez E, Cedro-tanda A, Mendoza-vargas A, Reyes-grajeda JP, Hidalgo-miranda A, Herrera LA. Analytical Performances of the COVISTIXTM Antigen Rapid Test for SARS-CoV-2 Detection in an Unselected Population (All-Comers). Pathogens 2022;11:628. [DOI: 10.3390/pathogens11060628] [Reference Citation Analysis]
7 Bello-chavolla OY, Antonio-villa NE, Valdés-ferrer SI, Fermín-martínez CA, Fernández-chirino L, Ramírez-garcía D, Mancilla-galindo J, Kammar-garcía A, Ávila-funes JA, Zúñiga-gil CH, García-grimshaw M, Ceballos-liceaga SE, Carbajal-sandoval G, Montes-gonzález JA, Zaragoza-jiménez CA, García-rodríguez G, Cortés-alcalá R, Reyes-terán G, López-gatell H, Gutiérrez-robledo LM. Effectiveness of a nation-wide COVID-19 vaccination program in Mexico.. [DOI: 10.1101/2022.04.04.22273330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Fernández-Rojas MA, Luna-Ruiz Esparza MA, Campos-Romero A, Calva-Espinosa DY, Moreno-Camacho JL, Mendlovic F, Plett-Torres T, Alcántar-Fernández J. Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico. Sci Rep 2022;12:5241. [PMID: 35347208 DOI: 10.1038/s41598-022-09395-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jimenez JV, Olivas-martinez A, Rios-olais FA, Ayala-aguillón F, Gil- López F, Leal-villarreal MADJ, Rodríguez-crespo JJ, Jasso-molina JC, Enamorado-cerna L, Dardón-fierro FE, Martínez-guerra BA, Román-montes CM, Alvarado-avila PE, Juárez-meneses NA, Morales-paredes LA, Chávez-suárez A, Gutierrez-espinoza IR, Najera-ortíz MP, Martínez-becerril M, Gonzalez-lara MF, Ponce de León-garduño A, Baltazar-torres JÁ, Rivero-sigarroa E, Dominguez-cherit G, Hyzy RC, Kershenobich D, Sifuentes-osornio J. Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19–Induced Acute Respiratory Distress Syndrome. Critical Care Explorations 2022;4:e0668. [DOI: 10.1097/cce.0000000000000668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Haan TJ, Smith LK, Deronde S, House E, Zidek J, Puhak D, Redlinger M, Parker J, Barnes BM, Burkhead JL, Knall C, Bortz E, Chen J, Drown DM. Founder effect contributes to the unique pattern of SARS-CoV-2 variant B.1.1.519 emergence in Alaska.. [DOI: 10.1101/2022.03.17.22272446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Biswas B, Chattopadhyay S, Hazra S, Hansda AK, Goswami R. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines. Inflamm Res 2022. [PMID: 35292834 DOI: 10.1007/s00011-022-01555-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cisneros-villanueva M, Blancas S, Cedro-tanda A, Ríos-romero M, Hurtado-córdova E, Almaraz-rojas O, Ortiz-soriano DR, Álvarez-hernández V, Arriaga-guzmán IE, Tolentino-garcía L, Sánchez-vizcarra A, Lozada-rodríguez LF, Peralta-arrieta I, Pérez-aquino JE, Andonegui-elguera MA, Cendejas-orozco M, Mendoza-vargas A, Reyes-grajeda JP, Campos-romero A, Alcantar-fernández J, Luis Moreno-camacho J, Gallegos-rodriguez J, Esparza-luna-ruiz M, Ortiz-ramirez J, Gonzalez MB, Uribe-figueroa L, Ruiz R, Angulo O, Herrera LA, Hidalgo-miranda A. Validation of the RT-LAMP assay in a large cohort of nasopharyngeal swab samples shows that it is a useful screening method for detecting SARS-CoV-2 and its VOC variants.. [DOI: 10.1101/2022.02.15.22270954] [Reference Citation Analysis]
13 Campos FS, de Arruda LB, da Fonseca FG. Special Issue “Viral Infections in Developing Countries”. Viruses 2022;14:405. [DOI: 10.3390/v14020405] [Reference Citation Analysis]
14 Ponce-de-León S, Torres M, Soto-Ramírez LE, José Calva J, Santillán-Doherty P, Carranza-Salazar DE, Carreño JM, Carranza C, Juárez E, Carreto-Binaghi LE, Ramírez-Martínez L, la Rosa GP, Vigueras-Moreno R, Ortiz-Stern A, López-Vidal Y, Macías AE, Torres-Flores J, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Kawabata H, González-Domínguez I, Martínez-Guevara JL, Sun W, Sarfati-Mizrahi D, Soto-Priante E, Chagoya-Cortés HE, López-Macías C, Castro-Peralta F, Palese P, García-Sastre A, Krammer F, Lozano-Dubernard B. Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico. medRxiv 2022:2022. [PMID: 35169806 DOI: 10.1101/2022.02.08.22270676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Cedro-tanda A, Gómez-romero L, Anda-jauregui GD, Garnica-lópez D, Alfaro-mora Y, Sánchez-xochipa S, García-garcía FE, Mendoza-vargas A, Frías-jiménez JE, Moreno-quiroga B, Campos-romero A, Luis Moreno-camacho J, Alcantar-fernández J, Ortíz-ramírez J, Benitez-gonzalez M, Trejo-gonzalez R, Aguirre-chavarria D, Núñez-martínez ME, Uribe-figueroa L, Angulo O, Ruiz R, Hidalgo-miranda A, Herrera LA. Early genomic, epidemiological, and clinical description of the SARS-CoV-2 Omicron variant in Mexico City.. [DOI: 10.1101/2022.02.06.22270482] [Reference Citation Analysis]
16 Sifuentes-osornio J, Angulo-guerrero O, De-anda-jáuregui G, Díaz-de-león-santiago JL, Hernández-lemus E, Benítez-pérez H, Herrera LA, López-arellano O, Revuelta-herrera A, Rosales-tapia AR, Ruiz-gutiérrez R, Suárez-lastra M, Sheinbaum-pardo C, Kershenobich D. PROBABILITY OF HOSPITALIZATION AND DEATH AMONG COVID-19 PATIENTS WITH COMORBIDITY DURING OUTBREAKS OCCURRING IN MEXICO CITY.. [DOI: 10.1101/2021.12.07.21267287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]